MRI radiomics-based machine learning for preoperative prediction of Simpson grade in intracranial meningiomas: a pilot study

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: meningiomas are the most frequent primary central nervous system tumors, and extent of resection is a key determinant of long-term tumor control. Quantitative preoperative MRI radiomics may support surgical planning by estimating the likelihood of achieving Simpson grade I versus II resection. This study evaluated the feasibility of an MRI radiomics-based machine learning approach for this purpose. Methods: a retrospective pilot study (2018–2024) included adults with intracranial meningioma and adequate preoperative contrast-enhanced T1-weighted MRI. Tumors were segmented in 3D Slicer and radiomic features were extracted using PyRadiomics under IBSI-compliant settings. The endpoint was binary (Simpson grade I vs II). Model selection used a selector–classifier benchmark with internal validation via nested leave-one-out cross-validation to mitigate data leakage. Performance was assessed using balanced accuracy, AUROC, AUPRC, and calibration (intercept, slope, Brier score). Uncertainty was estimated using bootstrap on out-of-fold predictions. Results: out of approximately 70 screened cases, 12 were included for modeling (Simpson I=4; Simpson II=8) with 126 candidate predictors. The best-performing configuration was LASSO (C=0.2) combined with linear discriminant analysis, achieving balanced accuracy 0.812, AUROC 0.844, AUPRC 0.867, and Brier score 0.129. Calibration was close to ideal (intercept ≈0.00; slope ≈0.97). Bootstrap 95% confidence intervals reflected uncertainty consistent with the small sample size. Conclusions: this pilot study supports the feasibility of a standardized MRI radiomics-based model for preoperative estimation of surgical resectability (Simpson I vs II) in intracranial meningiomas. Multicenter external validation is required to confirm generalizability and clinical utility.

Article activity feed